Stevanato Group (STVN) Executive Chairman On Biopharma & Engineering

Stevanato Group (STVN) is an Italy-based medical company that operates in Europe, Brazil, China, Mexico, and the U.S. Executive Chairman of STVN, Franco Stevanato joins Oliver Renick to discuss the company. He talks about how STVN's segments include biopharmaceuticals and diagnostic solutions, and engineering. He goes over STVN's earnings as its 1Q adjusted EPS came in at $0.13 versus an estimated $0.12 and 1Q revenue came in at $255.33M versus an estimated $250.81M. He notes that STVN's biopharma and diagnostics solutions segment revenue grew 13% and its 1Q engineering segment revenue grew 7%. Tune in to find out more about the stock market today.